Evidence map›Paper›PMID 37806488›Full record

ArticleJournal of cardiac failure2024

The HFSA Advanced Heart Failure and Transplant Cardiology Fellowship Consensus Conference.

Mark H Drazner, Amrut V Ambardekar, Kathryn Berlacher, Vanessa Blumer, Safia Chatur, Richard Cheng, Richard K Cheng, E Wilson Grandin, Eiran Z Gorodeski, Rachna Kataria and 13 more

Abstract readConsensus Statement
In one paragraph

Article in Journal of cardiac failure, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Charting the Course for Careers in Interventional Heart Failure: Training, Challenges, and Future Directions.Journal of the Society for Cardiovascular Angiography & Interventions · 2025
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Mark H DraznerDivision of Cardiology, University of Texas Southwestern Medical Center, Dallas, Texas. Electronic address: Mark.drazner@UTsouthwestern.edu.
Amrut V AmbardekarDepartment of Medicine, Division of Cardiology; University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Kathryn BerlacherHeart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Vanessa BlumerInova Schar and Vascular Institute, Falls Church, Virginia.
Safia ChaturCardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Richard ChengDivision of Cardiology, Department of Internal Medicine; University of California San Francisco, San Francisco, California.
Richard K ChengDivision of Cardiology, University of Washington, Seattle, Washington.
E Wilson GrandinDivision of Cardiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
Eiran Z GorodeskiHarrington Heart & Vascular Institute, University Hospitals, and Case Western Reserve University School of Medicine, Cleveland, Ohio.
Rachna KatariaDepartment of Cardiology, Lifespan Cardiovascular Institute, Brown University, Providence, Rhode Island.
Jason N KatzDivision of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina.
Michelle M KittlesonDepartment of Cardiology, Smidt Heart Institute-Cedars Sinai Medical Center, Los Angeles, California.
Arun KrishnamoorthyPiedmont Heart Institute; Atlanta, Georgia.
Anuradha LalaZena and Michael A. Wiener Cardiovascular Institute & Department of Population Health Science & Policy at Icahn School of Medicine at Mount Sinai, New York, New York.
Andrew J LennemanDivision of Cardiovascular Disease; University of Alabama at Birmingham, Birmingham, Alabama.
Nicole L LohrDivision of Cardiovascular Disease; University of Alabama at Birmingham, Birmingham, Alabama.
Kenneth B MarguliesDivision of Cardiovascular Medicine, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
Robert J MentzDivision of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina.
Nosheen RezaDivision of Cardiovascular Medicine, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
Jane WilcoxDivision of Cardiovascular Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Quentin R YoumansDivision of Cardiovascular Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Shelley ZierothSection of Cardiology, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
John R TeerlinkSection of Cardiology, San Francisco Veterans Affairs Medical Center and School of Medicine, University of California San Francisco, San Francisco, California.

Funding

Improving the Detection of Hypertrophic Cardiomyopathy Using Machine Learning Applied to Electronic Health Record DataK23HL166961 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI Nosheen Reza · 2023 to 2026
$691k
NHLBI NIH HHS K23 HL166961
6 · The paper itself

Abstract

There is waning interest among cardiology trainees in pursuing an Advanced Heart Failure/Transplant Cardiology (AHFTC) fellowship as evidenced by fewer applicants in the National Resident Matching Program match to this specialty. This trend has generated considerable attention across the heart failure community. In response, the Heart Failure Society of America convened the AHFTC Fellowship Task Force with a charge to develop strategies to increase the value proposition of an AHFTC fellowship. Subsequently, the HFSA sponsored the AHFTC Fellowship Consensus Conference April 26-27, 2023. Before the conference, interviews of 44 expert stakeholders diverse across geography, site of practice (traditional academic medical center or other centers), specialty/area of expertise, sex, and stage of career were conducted virtually. Based on these interviews, potential solutions to address the declining interest in AHFTC fellowship were categorized into five themes: (1) alternative training pathways, (2) regulatory and compensation, (3) educational improvements, (4) exposure and marketing for pipeline development, and (5) quality of life and mental health. These themes provided structure to the deliberations of the AHFTC Fellowship Consensus Conference. The recommendations from the Consensus Conference were subsequently presented to the HFSA Board of Directors to inform strategic plans and interventions. The HFSA Board of Directors later reviewed and approved submission of this document. The purpose of this communication is to provide the HF community with an update summarizing the processes used and concepts that emerged from the work of the HFSA AHFTC Fellowship Task Force and Consensus Conference.

Indexed as

CardiologyHeart FailureFellowships and ScholarshipsHumansQuality of Lifeclinical competenceeducationfellowshipHeart failuretrainingtransplantation

Identifiers

PMID37806488
PMCPMC11540483

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.